This forecasting study analyzes the impact of the Inflation Reduction Act (IRA) on diabetes drug costs for Medicare in Louisiana, USA. It finds that price negotiations for three non-insulin drugs are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback